Author's Biography |
|
xvii | |
Biographies of Contributors |
|
xix | |
Preface |
|
xxi | |
Foreword |
|
xxiii | |
Acknowledgments |
|
xxv | |
1 Introduction |
|
1 | (14) |
|
|
1 | (3) |
|
|
1 | (1) |
|
|
2 | (1) |
|
|
3 | (1) |
|
1.1.4 Advantages and Limitations |
|
|
4 | (1) |
|
1.1.5 Ultra-High-Pressure Liquid Chromatography (UHPLC) |
|
|
4 | (1) |
|
1.2 Primary Modes of HPLC |
|
|
4 | (6) |
|
1.2.1 Normal-Phase Chromatography (NPC) |
|
|
5 | (1) |
|
1.2.2 Reversed-Phase Chromatography (RPC) |
|
|
5 | (1) |
|
1.2.3 Ion-Exchange Chromatography (IEC) |
|
|
6 | (2) |
|
1.2.4 Size-Exclusion Chromatography (SEC) |
|
|
8 | (1) |
|
1.2.5 Other Separation Modes |
|
|
8 | (2) |
|
1.3 Some Common-Sense Corollaries |
|
|
10 | (1) |
|
1.4 How to Get More Information |
|
|
11 | (1) |
|
|
11 | (1) |
|
|
11 | (1) |
|
|
12 | (1) |
|
|
12 | (3) |
2 Basic Terms and Concepts |
|
15 | (30) |
|
|
15 | (1) |
|
2.2 Basic Terms and Concepts |
|
|
16 | (8) |
|
2.2.1 Retention Time (tR), Void Time (tM), Peak Height (h), and Peak Width (wb) |
|
|
16 | (1) |
|
2.2.2 Retention Volume (VR), Void Volume (VM), and Peak Volume |
|
|
16 | (2) |
|
2.2.3 Retention Factor (k) |
|
|
18 | (1) |
|
2.2.4 Separation Factor (α) |
|
|
19 | (1) |
|
2.2.5 Column Efficiency and Plate Number (N) |
|
|
20 | (1) |
|
|
20 | (1) |
|
2.2.7 Height Equivalent to a Theoretical Plate or Plate Height (HETP or H) |
|
|
21 | (1) |
|
|
21 | (2) |
|
2.2.9 Peak Symmetry: Asymmetry Factor (As) and Tailing Factor (Tf) |
|
|
23 | (1) |
|
|
24 | (7) |
|
2.3.1 General Requirements |
|
|
24 | (1) |
|
2.3.2 Solvent Strength and Selectivity |
|
|
25 | (2) |
|
2.3.3 pH Modifiers and Buffers |
|
|
27 | (1) |
|
2.3.4 Acidic Mobile Phases |
|
|
28 | (1) |
|
2.3.5 Ion-Pairing Reagents and Chaotropic Agents |
|
|
29 | (1) |
|
2.3.6 High-pH Mobile Phases |
|
|
29 | (1) |
|
2.3.7 Other Operating Parameters: Flow Rate (F) and Column Temperature (T) |
|
|
30 | (1) |
|
2.4 The Resolution Equation |
|
|
31 | (2) |
|
2.5 The Van Deemter Equation |
|
|
33 | (2) |
|
2.6 Isocratic vs. Gradient Analysis |
|
|
35 | (3) |
|
|
35 | (1) |
|
2.6.2 Gradient Parameters (Initial and Final Solvent Strength, Gradient Time (tG), and Flow Rate) |
|
|
36 | (1) |
|
2.6.3 The 0.25 ΔtG Rule: When Is Isocratic Analysis More Appropriate? |
|
|
37 | (1) |
|
2.7 The Concept of Orthogonality and Selectivity Tuning |
|
|
38 | (3) |
|
|
41 | (1) |
|
2.9 Glossary of HPLC Terms |
|
|
41 | (1) |
|
2.10 Summary and Conclusion |
|
|
42 | (1) |
|
|
42 | (2) |
|
|
44 | (1) |
|
|
44 | (1) |
3 HPLC Columns and Trends |
|
45 | (36) |
|
|
45 | (1) |
|
3.1.1 Glossary and Abbreviations |
|
|
45 | (1) |
|
3.2 General Column Description and Characteristics |
|
|
46 | (1) |
|
3.2.1 Column Hardware - Standard vs. Cartridge Format |
|
|
47 | (1) |
|
|
47 | (3) |
|
3.3.1 Types Based on Chromatographic Mode |
|
|
48 | (1) |
|
3.3.2 Column Types Based on Dimension |
|
|
48 | (1) |
|
|
48 | (2) |
|
3.4 Column Packing Characteristics |
|
|
50 | (4) |
|
|
50 | (1) |
|
|
51 | (1) |
|
3.4.3 Surface Area and Pore Size (dpore) |
|
|
51 | (1) |
|
3.4.4 Bonding Chemistries |
|
|
52 | (2) |
|
3.5 Modern HPLC Column Trends |
|
|
54 | (15) |
|
3.5.1 Silica Support Material |
|
|
54 | (1) |
|
|
55 | (3) |
|
3.5.3 Novel Bonding Chemistries |
|
|
58 | (3) |
|
3.5.3.1 Bonded Phases for Retention of Polar Analytes |
|
|
59 | (2) |
|
3.5.3.2 Charged Surface Hybrid (CSH) |
|
|
61 | (1) |
|
3.5.4 Shorter and Narrower Columns Packed with Small Particles |
|
|
61 | (1) |
|
|
61 | (1) |
|
|
62 | (1) |
|
3.5.5 Micro-LC and Nano-LC |
|
|
62 | (2) |
|
|
64 | (1) |
|
3.5.7 Superficially Porous Particles (SPP) |
|
|
65 | (2) |
|
3.5.7.1 Kinetic Plots Demonstrating the Superiority of SPP |
|
|
66 | (1) |
|
3.5.8 Micropillar Array Chromatography (µPAC) |
|
|
67 | (2) |
|
|
69 | (1) |
|
|
69 | (4) |
|
3.7.1 Bioseparations Columns |
|
|
69 | (1) |
|
|
69 | (2) |
|
3.7.3 Supercritical Fluid Chromatography (SFC) Columns |
|
|
71 | (1) |
|
3.7.4 Hydrophilic Interaction Liquid Chromatography (HILIC) Columns |
|
|
72 | (1) |
|
3.7.5 Mixed-Mode Chromatography (MMC) Columns |
|
|
72 | (1) |
|
3.7.6 Application-Specific Columns |
|
|
73 | (1) |
|
3.8 RPC Column Selection Guides |
|
|
73 | (3) |
|
3.8.1 Some General Guidelines for Bonded Phase Selection |
|
|
75 | (1) |
|
|
76 | (1) |
|
|
76 | (2) |
|
|
78 | (1) |
|
|
78 | (3) |
4 HPLC/UHPLC Instrumentation and Trends |
|
81 | (36) |
|
|
81 | (2) |
|
|
81 | (1) |
|
4.1.2 HPLC Systems and Modules |
|
|
81 | (2) |
|
4.1.3 Ultra-High-Pressure Liquid Chromatography (UHPLC) |
|
|
83 | (1) |
|
4.2 HPLC and UHPLC Solvent Delivery Systems |
|
|
83 | (5) |
|
4.2.1 High-Pressure and Low-Pressure Mixing Designs in Multisolvent Pumps |
|
|
85 | (1) |
|
4.2.2 System Dwell Volume |
|
|
86 | (2) |
|
4.2.2.1 Dwell Volumes of UHPLC Systems |
|
|
87 | (1) |
|
|
88 | (1) |
|
4.3 Injectors and Autosamplers |
|
|
88 | (3) |
|
4.3.1 Operating Principles of Autosamplers |
|
|
88 | (1) |
|
4.3.2 Performance Characteristics and Trends |
|
|
89 | (2) |
|
|
91 | (1) |
|
4.5 UV/VIS Absorbance Detectors |
|
|
92 | (2) |
|
4.5.1 Operating Principles |
|
|
92 | (2) |
|
4.5.2 Performance Characteristics |
|
|
94 | (1) |
|
4.5.3 Trends in UV/Vis Absorbance Detectors |
|
|
94 | (1) |
|
4.6 Photodiode Array Detectors |
|
|
94 | (1) |
|
4.6.1 Operating Principles |
|
|
94 | (1) |
|
4.6.2 Trends in PDA Detectors |
|
|
95 | (1) |
|
|
95 | (4) |
|
4.7.1 Refractive Index Detector (RID) |
|
|
96 | (1) |
|
4.7.2 Evaporative Light Scattering Detector (ELSD) |
|
|
96 | (1) |
|
4.7.3 Charged Aerosol Detector (CAD) |
|
|
97 | (1) |
|
4.7.4 Conductivity Detector (CD) |
|
|
97 | (1) |
|
4.7.5 Fluorescence Detector (FLD) |
|
|
97 | (1) |
|
4.7.5.1 Postcolumn Reaction Technique |
|
|
98 | (1) |
|
4.7.6 Chemiluminescence Nitrogen Detector (CLND) |
|
|
98 | (1) |
|
4.7.7 Electrochemical Detector (ECD) |
|
|
99 | (1) |
|
4.7.8 Radiometric Detector |
|
|
99 | (1) |
|
4.8 Hyphenated and Specialized Systems |
|
|
99 | (6) |
|
|
99 | (1) |
|
|
100 | (2) |
|
4.8.3 Other Hyphenated Systems |
|
|
102 | (1) |
|
4.8.4 Supercritical Fluid Chromatography (SFC) |
|
|
102 | (1) |
|
4.8.5 Preparative LC and SFC |
|
|
102 | (1) |
|
4.8.6 Micro- and Nano-LC (Capillary LC) |
|
|
102 | (1) |
|
4.8.7 Multidimensional LC |
|
|
102 | (2) |
|
|
104 | (1) |
|
4.8.9 Specialized Applications Systems |
|
|
104 | (1) |
|
4.8.9.1 Gel-Permeation Chromatography (GPC) |
|
|
104 | (1) |
|
4.8.9.2 Ion Chromatography (IC) |
|
|
105 | (1) |
|
4.8.9.3 Application-Specific Systems |
|
|
105 | (1) |
|
|
105 | (1) |
|
|
105 | (1) |
|
|
105 | (1) |
|
4.9.3 Valves for Column and Mobile Phase Selection |
|
|
106 | (1) |
|
4.10 Chromatography Data Systems (CDS) |
|
|
106 | (2) |
|
4.10.1 User Interface and CDS Workflow |
|
|
107 | (1) |
|
4.11 Instrumental Bandwidth (IBW) |
|
|
108 | (3) |
|
4.11.1 How to Measure IBW |
|
|
109 | (1) |
|
4.11.2 IBW of UHPLC Systems |
|
|
110 | (1) |
|
4.12 Manufacturers and Equipment Selection |
|
|
111 | (1) |
|
4.13 Trends in HPLC and UHPLC Equipment |
|
|
111 | (1) |
|
|
112 | (1) |
|
|
112 | (2) |
|
|
114 | (1) |
|
|
114 | (3) |
5 UHPLC: Perspectives, Performance, Practices, and Potential Issues |
|
117 | (30) |
|
|
117 | (3) |
|
|
117 | (1) |
|
5.1.2 Glossary and Abbreviations |
|
|
117 | (1) |
|
5.1.3 Historical Perspectives: What is UHPLC? |
|
|
118 | (2) |
|
5.2 Practical Concepts in UHPLC |
|
|
120 | (2) |
|
5.2.1 Rationale for Higher System Pressure |
|
|
120 | (1) |
|
5.2.2 Rationale for Low-Dispersion Systems |
|
|
121 | (1) |
|
5.2.3 Rationale for Low Dwell Volumes |
|
|
121 | (1) |
|
5.2.4 Other UHPLC Instrumental Characteristics |
|
|
122 | (1) |
|
5.3 Benefits Of UHPLC and Case Studies |
|
|
122 | (10) |
|
5.3.1 Benefit #1: Fast Separations with Good Resolution |
|
|
122 | (2) |
|
5.3.2 Benefit #2: High-Resolution Analysis of Complex Samples |
|
|
124 | (1) |
|
5.3.3 Benefit #3: Rapid HPLC Method Development |
|
|
124 | (5) |
|
5.3.4 Flexibility for Customizing Resolution |
|
|
129 | (1) |
|
5.3.5 Other Benefits of UHPLC |
|
|
130 | (2) |
|
|
130 | (1) |
|
5.3.5.2 Higher Mass Sensitivity in UV Detection |
|
|
130 | (1) |
|
5.3.5.3 Higher Precision Performance for Retention Time and Peak Area |
|
|
130 | (1) |
|
5.3.5.4 UHPLC are Compatible with Other Approaches |
|
|
131 | (1) |
|
5.4 Potential Issues and How to Mitigate |
|
|
132 | (7) |
|
|
132 | (1) |
|
|
133 | (1) |
|
5.4.3 Instrumental and Operating Nuances |
|
|
133 | (2) |
|
|
135 | (1) |
|
5.4.5 UV Detection Noise vs. Mixer Volumes |
|
|
135 | (3) |
|
5.4.6 Method Translation (Conversion) |
|
|
138 | (1) |
|
5.4.6.1 Running the Same HPLC Methods on HPLC and UHPLC |
|
|
138 | (1) |
|
5.4.6.2 Back Conversion of UHPLC Methods to HPLC Method Conditions |
|
|
139 | (1) |
|
5.4.6.3 Conversion of Existing HPLC Methods to Faster UHPLC Methods |
|
|
139 | (1) |
|
5.4.6.4 Method Validation Requirements After Method Translation |
|
|
139 | (1) |
|
5.5 How to Implement UHPLC and Practical Aspects |
|
|
139 | (3) |
|
5.5.1 How to Transition from HPLC to UHPLC |
|
|
139 | (1) |
|
|
140 | (1) |
|
5.5.3 A Summary of UHPLC System Performance Tradeoffs |
|
|
140 | (2) |
|
|
142 | (1) |
|
5.7 Summary and Conclusions |
|
|
142 | (1) |
|
|
142 | (2) |
|
|
144 | (1) |
|
|
144 | (3) |
6 LC/MS: Fundamentals, Perspectives, and Applications |
|
147 | (30) |
|
|
|
147 | (3) |
|
|
147 | (1) |
|
6.1.2 LC/MS Technology and Instrumentation |
|
|
147 | (1) |
|
6.1.3 Basic Terminologies and Concepts for MS |
|
|
148 | (2) |
|
6.1.4 Interfacing HPLC and MS |
|
|
150 | (1) |
|
6.2 LC/MS Instrumentation |
|
|
150 | (7) |
|
|
150 | (2) |
|
|
152 | (1) |
|
|
153 | (2) |
|
|
155 | (2) |
|
6.3 Small-Molecules Drug Research and Development |
|
|
157 | (7) |
|
6.3.1 Mass Measurement and Elemental Composition Determination |
|
|
157 | (2) |
|
6.3.2 Structural Elucidation |
|
|
159 | (3) |
|
|
162 | (2) |
|
6.4 Emerging Biopharmaceutical Applications |
|
|
164 | (7) |
|
6.4.1 Intact Mass Measurement of Proteins |
|
|
166 | (1) |
|
6.4.2 Structural Characterization of Proteins (Bottom-Up and Top-Down Approaches) |
|
|
166 | (4) |
|
6.4.3 Peptide Quantitation |
|
|
170 | (1) |
|
6.5 Environmental, Food Safety, Clinical, Toxicology, and "Omics" Applications |
|
|
171 | (1) |
|
|
171 | (1) |
|
|
172 | (5) |
|
|
174 | (1) |
|
|
174 | (3) |
7 HPLC/UHPLC Operation Guide |
|
177 | (22) |
|
|
177 | (1) |
|
7.2 Safety and Environmental Concerns |
|
|
177 | (3) |
|
|
177 | (2) |
|
7.2.2 Environmental Concerns |
|
|
179 | (1) |
|
7.3 Mobile Phase and Sample Preparation |
|
|
180 | (2) |
|
7.3.1 Mobile Phase Premixing |
|
|
180 | (1) |
|
7.3.2 Mobile Phase Additives and Buffers |
|
|
180 | (1) |
|
|
180 | (1) |
|
|
181 | (1) |
|
7.3.5 Samples, Diluents, and Sample Preparation |
|
|
181 | (1) |
|
7.4 Best Practices in HPLC/UHPLC System Operation |
|
|
182 | (7) |
|
|
182 | (1) |
|
7.4.2 HPLC Column Use, Precaution, Connection, and Maintenance |
|
|
183 | (1) |
|
|
183 | (1) |
|
7.4.2.2 Column Precautions |
|
|
183 | (1) |
|
7.4.2.3 Column Connections |
|
|
183 | (1) |
|
7.4.2.4 Column Maintenance and Regeneration |
|
|
184 | (1) |
|
7.4.3 Autosampler Operation |
|
|
184 | (2) |
|
7.4.4 Column Oven and Switching Valve |
|
|
186 | (1) |
|
7.4.5 UV/Vis Detector Operation |
|
|
186 | (1) |
|
7.4.6 HPLC System Shutdown |
|
|
187 | (1) |
|
7.4.7 Guidelines for Increasing HPLC Precision |
|
|
187 | (2) |
|
7.4.7.1 Guidelines for Improving Retention Time Precision |
|
|
187 | (1) |
|
7.4.7.2 Guidelines for Improving Peak Area Precision |
|
|
188 | (1) |
|
7.5 From Chromatograms to Reports |
|
|
189 | (4) |
|
7.5.1 Qualitative Analysis Strategies |
|
|
192 | (1) |
|
7.5.2 Quantitation Analysis Strategies |
|
|
192 | (1) |
|
7.6 Summary of HPLC Operation |
|
|
193 | (1) |
|
7.7 Guides on Performing Trace Analysis |
|
|
193 | (2) |
|
|
195 | (1) |
|
|
195 | (1) |
|
|
196 | (1) |
|
|
196 | (3) |
8 HPLC/UHPLC Maintenance and Troubleshooting |
|
199 | (22) |
|
|
199 | (1) |
|
8.2 HPLC System Maintenance |
|
|
199 | (5) |
|
|
200 | (2) |
|
8.2.2 UV/Vis Absorbance or Photodiode Array Detectors (PDA) |
|
|
202 | (2) |
|
8.2.3 Injector and Autosampler |
|
|
204 | (1) |
|
|
204 | (9) |
|
8.3.1 General Problem Diagnostic and Troubleshooting Guide |
|
|
205 | (1) |
|
8.3.2 Common HPLC Problems |
|
|
206 | (7) |
|
8.3.2.1 Pressure Problems and Causes |
|
|
207 | (1) |
|
8.3.2.2 Baseline Problems (Chromatogram) |
|
|
207 | (3) |
|
8.3.2.3 Peak Problems (Chromatogram) |
|
|
210 | (3) |
|
8.3.2.4 Data Performance Problems |
|
|
213 | (1) |
|
8.4 Troubleshooting Case Studies |
|
|
213 | (4) |
|
8.4.1 Case Study 1: Reducing Baseline Shift and Noise for Gradient Analysis |
|
|
213 | (1) |
|
8.4.2 Case Study 2: Poor Peak Area Precision |
|
|
214 | (1) |
|
8.4.3 Case Study 3: Poor Assay Accuracy Data |
|
|
215 | (1) |
|
8.4.4 Case Study 4: Equipment Malfunctioning and Problems with Blank |
|
|
216 | (1) |
|
8.5 Summary and Conclusion |
|
|
217 | (1) |
|
|
218 | (1) |
|
|
219 | (1) |
|
|
219 | (2) |
9 Pharmaceutical Analysis |
|
221 | (24) |
|
|
221 | (1) |
|
|
221 | (1) |
|
9.1.2 Glossary and Abbreviations |
|
|
221 | (1) |
|
9.2 Overview of Drug Development Process |
|
|
222 | (2) |
|
9.3 Sample Preparation Perspectives |
|
|
224 | (1) |
|
9.4 HPLC, SFC, and HPLC/MS in Drug Discovery |
|
|
224 | (1) |
|
9.5 HPLC Testing Methodologies for DS and DP |
|
|
225 | (14) |
|
9.5.1 Identification Test (DS, DP) |
|
|
227 | (1) |
|
9.5.2 ASSAY (Rough Potency and Performance Testing, DP) |
|
|
227 | (3) |
|
9.5.2.1 Testing for Uniformity of Dosage Units |
|
|
227 | (1) |
|
9.5.2.2 Dissolution Testing |
|
|
228 | (2) |
|
9.5.3 Stability-Indicating Assay (Potency and Purity Testing of DS and DP) |
|
|
230 | (8) |
|
9.5.3.1 Trends in Stability-Indicating Methods |
|
|
230 | (1) |
|
9.5.3.2 Potency Determination (DS, DP) |
|
|
231 | (1) |
|
9.5.3.3 Qualification of Reference Standard for the API |
|
|
232 | (1) |
|
9.5.3.4 Quantitation of Impurities and Degradation Products (DS, DP) |
|
|
233 | (1) |
|
9.5.3.5 Case Study of an HPLC Method of an API with Multiple Chiral Centers |
|
|
234 | (2) |
|
9.5.3.6 Control of Chemical and Chiral Purities of Starting Materials for Multichiral APIs |
|
|
236 | (1) |
|
9.5.3.7 DP with Multiple APIs or Natural Products |
|
|
237 | (1) |
|
9.5.3.8 Stability Studies |
|
|
237 | (1) |
|
9.5.4 Assay of Preservatives |
|
|
238 | (1) |
|
9.5.5 Assay of Pharmaceutical Counterions |
|
|
238 | (1) |
|
9.5.6 Assay of Potential Genotoxic Impurities (PGI) |
|
|
239 | (1) |
|
9.6 Cleaning Verification |
|
|
239 | (1) |
|
9.7 Bioanalytical Testing |
|
|
240 | (2) |
|
|
242 | (1) |
|
|
242 | (1) |
|
|
243 | (1) |
|
|
243 | (2) |
10 HPLC Method Development |
|
245 | (36) |
|
|
245 | (1) |
|
|
245 | (1) |
|
10.1.2 Considerations Before Method Development |
|
|
245 | (1) |
|
10.1.3 HPLC Method Development Trends in Pharmaceutical Analysis |
|
|
246 | (1) |
|
10.2 A Five-Step Strategy for Traditional HPLC Method Development |
|
|
246 | (12) |
|
10.2.1 Step 1: Defining Method Types and Goals |
|
|
246 | (2) |
|
10.2.1.1 Method Goals and Acceptance Criteria for Quantitative Assays |
|
|
247 | (1) |
|
10.2.2 Step 2: Gathering Sample and Analyte Information |
|
|
248 | (1) |
|
10.2.3 Step 3: Initial HPLC Method Development |
|
|
248 | (5) |
|
10.2.3.1 Initial Detector Selection |
|
|
249 | (1) |
|
10.2.3.2 Selection of Chromatographic Mode |
|
|
250 | (1) |
|
10.2.3.3 Selecting Samples |
|
|
250 | (1) |
|
10.2.3.4 Initial Selection of HPLC Column and Mobile Phase |
|
|
251 | (1) |
|
10.2.3.5 Generating the First Chromatogram |
|
|
251 | (1) |
|
10.2.3.6 Case Study: Initial Purity Method Development of an NCE Using a Broad Gradient |
|
|
251 | (2) |
|
10.2.4 Step 4: Method Fine-Tuning and Optimization |
|
|
253 | (3) |
|
10.2.4.1 Mobile Phase Parameters (%B, pH, Buffer, Solvent Type) |
|
|
255 | (1) |
|
10.2.4.2 Operating Parameters (F, T, ΔΦ, tG, Gradient Segment) |
|
|
255 | (1) |
|
10.2.4.3 Column Parameters (Bonded Phase Type, L, dp, dc) |
|
|
255 | (1) |
|
10.2.4.4 Detector Setting and Sample Amount |
|
|
256 | (1) |
|
10.2.5 Step 5: Method Prequalification |
|
|
256 | (1) |
|
10.2.6 Summary of Method Development Steps |
|
|
257 | (1) |
|
10.2.7 Phase-Appropriate Method Development and Validation |
|
|
257 | (1) |
|
10.2.8 Method Development Software Tools |
|
|
258 | (1) |
|
|
258 | (10) |
|
10.3.1 A Phase-0 Drug Substance Method for an NCE |
|
|
259 | (1) |
|
10.3.2 Stability-Indicating Method Development for an NCE Using DryLab |
|
|
260 | (2) |
|
10.3.3 Stability-Indicating Method for a Combination Drug Product with Two APIs |
|
|
262 | (3) |
|
10.3.4 Automated Method Development System Employing Fusion QbD Software |
|
|
265 | (3) |
|
10.4 A Three-Pronged Template Approach for Rapid HPLC Method Development |
|
|
268 | (4) |
|
10.4.1 Template #1: Fast LC Isocratic Potency or Performance Methods |
|
|
269 | (1) |
|
10.4.2 Template #2: Generic Broad Gradient Methods |
|
|
270 | (1) |
|
10.4.3 Template #3: Multisegment Gradient Methods for NCEs |
|
|
271 | (1) |
|
10.4.4 Summary of the Three-Pronged Approach |
|
|
272 | (1) |
|
10.5 A Universal Generic Method for Pharmaceutical Analysis |
|
|
272 | (4) |
|
10.5.1 Rationales for the Generic Method Parameters |
|
|
272 | (1) |
|
10.5.2 Adjustment of the Generic Method for Stability-Indicating Assays |
|
|
273 | (2) |
|
10.5.3 Summary of the Universal Generic Method Approach |
|
|
275 | (1) |
|
10.6 Comments on Other HPLC Modes |
|
|
276 | (1) |
|
10.7 Summary and Conclusions |
|
|
276 | (1) |
|
|
277 | (1) |
|
|
278 | (1) |
|
|
278 | (3) |
11 Regulations, HPLC System Qualification, Method Validation, and Transfer |
|
281 | (24) |
|
|
281 | (1) |
|
|
281 | (1) |
|
11.1.2 Glossary and Abbreviations |
|
|
281 | (1) |
|
11.2 Regulatory Environment in the Pharmaceutical Industry |
|
|
281 | (4) |
|
|
283 | (1) |
|
11.2.1.1 Good Manufacturing Practice (GMP) |
|
|
283 | (1) |
|
11.2.1.2 International Council for Harmonization (ICH) Guidelines |
|
|
283 | (1) |
|
11.2.1.3 Good Laboratory Practice (GLP) |
|
|
284 | (1) |
|
11.2.2 The Role of the United States Food and Drug Administration (U.S. FDA) |
|
|
284 | (1) |
|
11.2.3 The United States Pharmacopeia (USP) |
|
|
284 | (1) |
|
11.3 HPLC System Qualification |
|
|
285 | (5) |
|
11.3.1 Design Qualification (DQ) |
|
|
285 | (1) |
|
11.3.2 Installation Qualification (IQ) |
|
|
285 | (2) |
|
11.3.3 Operational Qualification (OQ) |
|
|
287 | (1) |
|
11.3.4 Performance Qualification (PQ) |
|
|
287 | (1) |
|
11.3.5 System Qualification Documentation |
|
|
287 | (1) |
|
11.3.6 System Calibration |
|
|
287 | (2) |
|
11.3.7 System Suitability Testing (SST) |
|
|
289 | (1) |
|
|
290 | (8) |
|
11.4.1 Data Required for Method Validation |
|
|
291 | (5) |
|
|
291 | (1) |
|
11.4.1.2 Linearity and Range |
|
|
292 | (2) |
|
|
294 | (1) |
|
11.4.1.4 Precision: Repeatability, Reproducibility |
|
|
294 | (1) |
|
11.4.1.5 Sensitivity: Detection Limit and Quantitation Limit |
|
|
295 | (1) |
|
|
296 | (1) |
|
11.4.2 Case Studies and Summary Data on Method Validation |
|
|
296 | (2) |
|
|
298 | (1) |
|
|
298 | (1) |
|
11.7 Cost-Effective Regulatory Compliance Strategies |
|
|
298 | (4) |
|
11.7.1 Regulatory Compliance in Other Industries |
|
|
301 | (1) |
|
11.8 Summary and Conclusions |
|
|
302 | (1) |
|
|
302 | (1) |
|
|
303 | (1) |
|
|
303 | (2) |
12 HPLC and UHPLC for Biopharmaceutical Analysis |
|
305 | (30) |
|
|
|
|
305 | (3) |
|
12.2 Size-Exclusion Chromatography (SEC) |
|
|
308 | (4) |
|
|
308 | (1) |
|
12.2.2 SEC Theory and Fundamentals |
|
|
308 | (1) |
|
12.2.3 SEC Method Conditions |
|
|
309 | (2) |
|
|
311 | (1) |
|
12.3 Ion-Exchange Chromatography (IEC) |
|
|
312 | (2) |
|
|
312 | (1) |
|
12.3.2 IEC Theory and Fundamentals |
|
|
313 | (1) |
|
12.3.3 IEC Method Conditions |
|
|
313 | (1) |
|
|
314 | (1) |
|
12.4 Affinity Chromatography |
|
|
314 | (3) |
|
12.4.1 Affinity Chromatography Introduction |
|
|
314 | (1) |
|
12.4.2 Affinity Chromatography Theory and Fundamentals |
|
|
315 | (1) |
|
12.4.3 Affinity Chromatography Method Conditions |
|
|
315 | (1) |
|
12.4.4 Affinity Chromatography Applications |
|
|
316 | (1) |
|
12.5 Hydrophilic Interaction Liquid Chromatography (HILIC) |
|
|
317 | (3) |
|
12.5.1 HILIC Introduction |
|
|
317 | (1) |
|
12.5.2 HILIC Theory and Fundamentals |
|
|
317 | (1) |
|
12.5.3 HILIC Method Conditions |
|
|
318 | (1) |
|
12.5.4 HILIC Applications |
|
|
318 | (2) |
|
12.6 Reversed-Phase Chromatography (RPC) |
|
|
320 | (2) |
|
|
320 | (1) |
|
12.6.2 RPC Theory and Fundamentals |
|
|
320 | (1) |
|
12.6.3 RPC Method Conditions |
|
|
321 | (1) |
|
|
321 | (1) |
|
12.7 Hydrophobic Interaction Chromatography (HIC) |
|
|
322 | (2) |
|
|
322 | (1) |
|
12.7.2 HIC Theory and Fundamentals |
|
|
322 | (1) |
|
12.7.3 HIC Method Conditions |
|
|
323 | (1) |
|
|
324 | (1) |
|
12.8 Mixed-Mode Chromatography (MMC) |
|
|
324 | (2) |
|
|
324 | (1) |
|
12.8.2 MMC Theory and Fundamentals |
|
|
325 | (1) |
|
12.8.3 MMC Method Conditions |
|
|
325 | (1) |
|
|
325 | (1) |
|
12.9 Multidimensional Liquid Chromatography |
|
|
326 | (2) |
|
12.9.1 Multidimensional LC Introduction |
|
|
326 | (1) |
|
12.9.2 Multidimensional LC Theory and Fundamentals |
|
|
326 | (1) |
|
12.9.3 Multidimensional LC Method Conditions |
|
|
327 | (1) |
|
12.9.4 Multidimensional LC Applications |
|
|
327 | (1) |
|
|
328 | (1) |
|
|
328 | (1) |
|
|
329 | (6) |
13 HPLC Applications in Food, Environmental, Chemical, and Life Sciences Analysis |
|
335 | (36) |
|
|
335 | (1) |
|
|
335 | (1) |
|
|
335 | (14) |
|
13.2.1 Natural Food Components |
|
|
336 | (5) |
|
|
336 | (1) |
|
13.2.1.2 Fats, Oils, and Triglycerides |
|
|
337 | (1) |
|
13.2.1.3 Free Fatty Acids and Organic Acids |
|
|
338 | (2) |
|
13.2.1.4 Proteins and Amino Acids |
|
|
340 | (1) |
|
|
341 | (5) |
|
13.2.2.1 Flavors: A Case Study on HPLC Analysis of Capsaicins |
|
|
345 | (1) |
|
|
346 | (3) |
|
|
347 | (1) |
|
13.2.3.2 Antimicrobial Additives |
|
|
348 | (1) |
|
13.2.3.3 Pesticide Residues |
|
|
348 | (1) |
|
13.3 Environmental Applications |
|
|
349 | (3) |
|
13.3.1 Listing of U.S. EPA Test Methods Using HPLC |
|
|
349 | (1) |
|
13.3.2 Pesticides Analysis |
|
|
349 | (2) |
|
13.3.2.1 Carbamates and Glyphosate |
|
|
350 | (1) |
|
13.3.3 Polynuclear Aromatic Hydrocarbons (PAH) |
|
|
351 | (1) |
|
13.3.3.1 Case Study: Quick Turnaround Analysis of PAHs in Multimedia Samples |
|
|
351 | (1) |
|
13.3.4 HPLC Analysis of Carbonyl Compounds (Aldehydes and Ketone) |
|
|
352 | (1) |
|
13.4 Chemical Industry, GPC, and Plastics Applications |
|
|
352 | (4) |
|
13.4.1 Gel-Permeation Chromatography (GPC) and Analysis of Plastics Additives |
|
|
352 | (4) |
|
13.5 Ion Chromatography (IC) |
|
|
356 | (1) |
|
13.6 Life Sciences Applications |
|
|
356 | (10) |
|
13.6.1 Proteins, Peptides, and Amino Acids |
|
|
357 | (6) |
|
13.6.2 Bases, Nucleosides, Nucleotides, Oligonucleotides, and Nucleic Acids |
|
|
363 | (1) |
|
13.6.3 Bioscience Research in Proteomics, Metabolomics, Glycomics and Clinical Diagnostics |
|
|
363 | (3) |
|
|
366 | (1) |
|
|
366 | (2) |
|
|
368 | (1) |
|
|
368 | (3) |
Keys to Quizzes |
|
371 | (2) |
Index |
|
373 | |